Seeking Alpha

Inovio Pharmaceuticals soars on no specific news driver today

  • The volatility continues in Inovovio Pharmaceuticals (INO) today, with the stock rising over 32% on no significant news.
  • Last week, the stock too a 9% dip after Aegis cut the shares to Hold.
Comments (13)
  • It was also beat down the past couple weeks 60%+ on no news
    21 Aug 2013, 04:40 PM Reply Like
  • re inovio before the opening yesterday there
    was a halt in trading and rule SHO 201 was imposed
    i.d.'ing the stock as being under illegal manipulation,
    including naked short selling by bear raiders. i don't thnk it
    was a classic pump-a-dump, but after the raft of big news
    announcements and the run from under a buck to over 3.
    it became extremely overbought, the drop may also
    have accelerated by company selling of new shares
    pursuant to a standing S3 filing. their R & D needs
    constant funding. the raiders were aware of all these
    points, you can be sure.
    22 Aug 2013, 03:39 AM Reply Like
  • There is a new driver, there's a conference annoucement for a conference in Korea on Sep 11, speaker would be member of INO scientific board (and 2nd largest individual investor of INO), Merck would be there also talking about... vaccine licensing
    21 Aug 2013, 04:47 PM Reply Like
  • 3.50 price target by Piper Jaffery last night.
    21 Aug 2013, 05:14 PM Reply Like
  • I just read that Piper Jaffery issued that price target to its clients on August 12th.
    21 Aug 2013, 05:52 PM Reply Like
  • @tomlewis727... Ain't that the truth. Guess they forgot to mention HA
    21 Aug 2013, 05:20 PM Reply Like
  • The day traders are at play with their new toy.
    21 Aug 2013, 05:52 PM Reply Like
  • made money on it today........happy.
    21 Aug 2013, 06:12 PM Reply Like
  • classic pump and dump... daytrade this only
    21 Aug 2013, 06:19 PM Reply Like
  • INO is one of the best biotech stock today. Looking at it from strictly a scientific viewpoint, electroporation therapy is the wave of the future of cancer therapy-even the analysts who play games with their articles can't deny that. I want to buy more shares.
    21 Aug 2013, 10:10 PM Reply Like
  • Kyle you are right on the money.This is a brilliant analysis.
    Osth
    22 Aug 2013, 09:22 AM Reply Like
  • The volatility continues in Inovovio Pharmaceuticals (INO) today, with the stock rising over 32% on no significant news

     

    Dear seeking alpha,
    While some of the recent price rise the last few weeks was due to speculation of partnership. Inovio has released plenty of significant news as of late. You guys continue to publish your short articles with the questionable timing. On the flip side you release a article saying INO could be merck's solution. Thanks for your market games and continued manipulation. Now the fact is a big pharma partnership has been INO's goal for sometime. The CEO speaking in June told investors he expects a partnership in the next few months. The real title of your article should be due to naked shorting and continued spread of misinformation my media sources ino's stock has moved down for no apparent reason.

     

    These significant news releases over the first half of year might have something to with the over all higher share price.

     

    Jan 7, 2013
    PATH Malaria Vaccine Initiative and Inovio Pharmaceuticals Partner to Accelerate Development of Malaria Vaccines and Innovative Delivery Technologies

     

    Jan 9, 2013
    Inovio Pharmaceuticals to Initiate Clinical Trial for its Hepatitis C Therapeutic Vaccine (INO-8000) Later this Year

     

    Apr 10, 2013
    Inovio Pharmaceuticals & U.S. Army Receive $3.5 Million Biodefense Grant to Further Develop Mass Vaccination Device

     

    Apr 18, 2013
    Inovio Pharmaceuticals Universal H1N1 Influenza Vaccine Achieves Protective Immune Responses Comparable to Conventional Vaccine in Phase I Study

     

    Apr 18, 2013
    Inovio Pharmaceuticals Recognized With "Best Therapeutic Vaccine" and "Best Early Stage Biotech" Awards at World Vaccine Congress 2013

     

    May 14, 2013
    Inovio Pharmaceuticals DNA Vaccine Against Ebola and Marburg Filoviruses Provides Complete Protection in Preclinical Challenge Study

     

    Jun 14, 2013
    Inovio's Universal H7N9 DNA Vaccine Generates First Protective Antibody Responses Against Virulent H7N9 Virus in 100% of Vaccinated Animals

     

    Jul 8, 2013
    Inovio Pharmaceuticals' Universal H7N9 DNA Vaccine Protects 100% of Vaccinated Animals in Challenge Study

     

    Jul 10, 2013
    Inovio's CELLECTRA® Electroporation Delivery Technology Powers Durable, Best-in-Class T-Cell Responses from HIV Vaccine in Human Study

     

    Jul 18, 2013
    Synthetically Optimized HIF-1 Alpha DNA Delivered with Inovio's Electroporation Technology Provides Significant Therapeutic Effects for Peripheral Arterial Disease in Animal Model

     

    Jul 24, 2013
    Inovio Pharmaceuticals' Potent hTERT DNA Cancer Vaccine Shows Potential to Reduce Tumors and Prevent Tumor Recurrence

     

    Aug 15, 2013
    Inovio Pharmaceuticals' Malaria DNA Vaccine Demonstrates Robust Immune Responses in Animal Models

     

    (not to mention the 7 conferences their attending in September)
    22 Aug 2013, 03:40 AM Reply Like
  • But no news TODAY.
    Usually takes news to move a stock 5%+ in a day; especially 30%!
    22 Aug 2013, 08:08 PM Reply Like
DJIA (DIA) S&P 500 (SPY)